International legal practice Osborne Clarke has advised the sellers of design and product development firm, Kinneir Dufort, on its acquisition by the global medical device and contract manufacturing group, SteriPack.
Bristol-headquartered Kinneir Dufort fuses creative, technical and user-centred expertise to build innovative physical and digital products, supporting global Medical, Consumer and Industrial clients.
The move will further strengthen Kinneir Dufort's long-standing capability in healthcare and medical device design and development to support both existing and new clients as they address new challenges and opportunities, deliver on business outcomes and create experiences that drive demand.
The addition of Kinneir Dufort to the SteriPack Group will reinforce its global footprint and expand its design and development capability, creating a European Design and Development Centre of Excellence.
Kinneir Dufort’s long established purpose, ethos and values will remain unchanged, as will its 85-strong team led by existing directors, Kerry Briggs, Sam Reeves and Craig Wightman. Current CEO, Merle Hall will assume a group Design and Development role.
Merle, commented: "The Osborne Clarke team have been instrumental to the successful completion of this deal, not only in their immense knowledge and pragmatic advice throughout, but also as individuals with whom it is an absolute pleasure to work with daily. Dave’s reassuring approach, depth of experience and entire demeanour made this a trouble-free experience. I cannot recommend them highly enough as a firm and individuals."
Osborne Clarke's Corporate team was led by Partner and Head of Corporate team David Ferris and Associate Director Elinor Owen. Additional support was provided by Tax Partner Tracey Wright and Senior Associate Adam Turner.
David, said: "Having worked with Merle and the Kinnier Dufort team since 2016 when they completed their MBO with the support of Mobeus, it was a pleasure to support this talented team on the next stage of their journey. Kinneir Dufort's sale to the SteriPack Group will create even more opportunities and further accelerate global growth and client expansion."
Osborne Clarke’s Corporate team is a go-to practice for technology and innovation-focused businesses. Its clients range from global businesses to fast-growth start-ups and market challengers. The team advises at every stage of company development across all corporate issues, from equity and debt fundraisings to M&A, IPOs and JVs.
